Oppenheimer Asset Management Inc. Boosts Stock Holdings in CVS Health Corporation (NYSE:CVS)

Oppenheimer Asset Management Inc. increased its holdings in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 23.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 538,341 shares of the pharmacy operator's stock after acquiring an additional 102,470 shares during the quarter. Oppenheimer Asset Management Inc.'s holdings in CVS Health were worth $36,473,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the stock. Hopwood Financial Services Inc. bought a new position in shares of CVS Health in the 4th quarter valued at $29,000. McIlrath & Eck LLC grew its holdings in shares of CVS Health by 32.6% during the 4th quarter. McIlrath & Eck LLC now owns 707 shares of the pharmacy operator's stock valued at $32,000 after purchasing an additional 174 shares during the last quarter. Providence First Trust Co acquired a new position in CVS Health during the 4th quarter worth approximately $42,000. Park Square Financial Group LLC acquired a new stake in CVS Health in the fourth quarter valued at approximately $43,000. Finally, PARK CIRCLE Co grew its stake in shares of CVS Health by 42.9% during the fourth quarter. PARK CIRCLE Co now owns 1,000 shares of the pharmacy operator's stock worth $45,000 after buying an additional 300 shares during the last quarter. 80.66% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on CVS shares. Wells Fargo & Company restated an "overweight" rating and issued a $84.00 price target (up from $76.00) on shares of CVS Health in a research report on Tuesday, May 6th. Morgan Stanley reiterated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Mizuho raised their price objective on CVS Health from $70.00 to $76.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 9th. Cowen reissued a "buy" rating on shares of CVS Health in a research report on Monday, May 5th. Finally, Royal Bank Of Canada boosted their price target on shares of CVS Health from $74.00 to $81.00 and gave the stock an "outperform" rating in a research report on Monday, May 5th. Two equities research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $74.75.

Insider Activity at CVS Health

In other news, Director Guy P. Sansone acquired 1,570 shares of CVS Health stock in a transaction dated Thursday, June 5th. The shares were purchased at an average cost of $63.70 per share, for a total transaction of $100,009.00. Following the transaction, the director now owns 12,007 shares of the company's stock, valued at $764,845.90. This trade represents a 15.04% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through the SEC website. 1.22% of the stock is owned by insiders.

CVS Health Stock Performance

CVS stock traded up $1.07 during midday trading on Tuesday, reaching $67.88. 7,148,886 shares of the company's stock traded hands, compared to its average volume of 10,893,157. CVS Health Corporation has a 52 week low of $43.56 and a 52 week high of $72.51. The company has a 50-day moving average price of $64.88 and a two-hundred day moving average price of $60.53. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.63 and a current ratio of 0.82. The firm has a market capitalization of $85.87 billion, a PE ratio of 16.16, a price-to-earnings-growth ratio of 0.95 and a beta of 0.56.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. The firm had revenue of $94.59 billion during the quarter, compared to analyst estimates of $93.07 billion. CVS Health had a net margin of 1.39% and a return on equity of 10.59%. The business's revenue for the quarter was up 7.0% on a year-over-year basis. During the same period in the previous year, the business earned $1.31 EPS. As a group, equities analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current year.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.